Sorasak Intorasoot | Microbiology | Innovative Research Award

Published on by Medical Lab Scientist

Innovative Research Award

Sorasak Intorasoot
Chiang Mai University, Thailand

Sorasak Intorasoot
Affiliation Chiang Mai University
Country Thailand
Scopus ID 6506991699
Documents 32
Citations 358
h-index 11
Subject Area Microbiology
Event Medical Lab Scientist Awards
ORCID 0000-0002-7137-4750

Sorasak Intorasoot is a researcher affiliated with Chiang Mai University whose scholarly activities are associated with microbiology and related biomedical laboratory sciences. His publication profile demonstrates sustained contributions to microbial research, laboratory investigations, and scientific dissemination. The documented publication output, citation performance, and h-index indicate measurable academic influence within his field and provide a basis for evaluating research excellence and suitability for professional recognition.[1][2]

Abstract

Sorasak Intorasoot has established a scholarly profile within microbiology through contributions that address microbial biology, laboratory investigations, and biomedical research applications. His publication record demonstrates consistent participation in scientific studies that advance understanding of microorganisms and their relevance to health sciences. With 32 indexed documents, 358 citations, and an h-index of 11, his work reflects measurable academic visibility and influence. The researcher’s contributions support evidence-based laboratory practices, interdisciplinary collaboration, and knowledge dissemination within microbiological sciences. These achievements collectively illustrate sustained research productivity and scientific engagement suitable for academic recognition and professional distinction.[1][2]

Keywords

Microbiology; Microbial Research; Biomedical Laboratory Science; Laboratory Diagnostics; Scientific Publications; Citation Impact; Academic Research; Infectious Diseases; Experimental Biology; Research Excellence.

Introduction

Microbiological research plays a fundamental role in advancing healthcare, diagnostics, and biological sciences. Sorasak Intorasoot has contributed to this domain through research activities documented in international scholarly databases. His academic record reflects ongoing engagement with laboratory-based investigations and scientific communication within microbiology and related health disciplines.[3]

Research Profile

Affiliated with Chiang Mai University, Sorasak Intorasoot maintains an established research profile characterized by peer-reviewed publications, citation activity, and interdisciplinary scientific collaborations. His documented scholarly output demonstrates active participation in microbiological studies and laboratory science investigations relevant to contemporary biomedical research.[1][2]

Research Contributions

The researcher has contributed to studies involving microbial systems, laboratory methodologies, and biomedical applications. His work supports scientific understanding of microorganisms and promotes evidence-based approaches in microbiology. These contributions have been disseminated through peer-reviewed publications and recognized through citation by the broader scientific community.[1]

Publications

The publication portfolio includes 32 indexed scholarly documents covering microbiology and associated biomedical topics. These works contribute to scientific literature through experimental findings, laboratory analyses, and collaborative investigations that support ongoing developments within microbial and health-related research fields.[1]

Research Impact

Research impact is reflected through 358 citations and an h-index of 11, indicating continued scholarly engagement with the researcher’s published work. Citation-based metrics suggest that his studies have contributed useful knowledge to microbiology and related scientific disciplines while maintaining visibility within academic literature.[1]

Award Suitability

The combination of sustained publication activity, documented citation influence, institutional affiliation, and contributions to microbiological science supports consideration for the Innovative Research Award. These accomplishments demonstrate research productivity, scientific relevance, and professional engagement aligned with the objectives of academic recognition programs.[1][4]

Conclusion

Sorasak Intorasoot’s scholarly record reflects meaningful participation in microbiology research and scientific communication. His publication output, citation performance, and institutional contributions collectively demonstrate academic engagement and research effectiveness, supporting recognition through professional awards that acknowledge scientific achievement and continued advancement of knowledge.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Sorasak Intorasoot, Author ID 6506991699. Scopus. https://www.scopus.com/authid/detail.uri?authorId=6506991699
  2. ORCID. (n.d.). ORCID record for Sorasak Intorasoot (0000-0002-7137-4750). https://orcid.org/0000-0002-7137-4750
  3. Kaewma, W., Thanoi, V., Butr-Indr, B., Wattananandkul, U., Phunpae, P., Sitthidet Tharinjaroen, C., Sangboonruang, S., Intorasoot, A., & Intorasoot, S. (2025). A survey of foodborne bacterial contamination in Chiang Mai Province, Thailand: A pilot study focused on Aeromonas and Vibrio. Journal of Associated Medical Sciences. https://he01.tci-thaijo.org/index.php/bulletinAMS/article/view/277078
  4. Medical Lab Scientist Awards. (n.d.). Award information and recognition criteria. https://medicallabscientist.com/

Despina Bozoudi | Microbiology | Research Excellence Award

Published on by Medical Lab Scientist

Ms. Despina Bozoudi | Microbiology | Research Excellence Award

Public Health Inspector | Pafos Municipality | Cyprus

Ms. Despina Bozoudi is a researcher in food microbiology and dairy science with a strong focus on the microbiological, physicochemical, and molecular characterization of traditional fermented foods, particularly PDO cheeses and dairy products. Her research integrates microbial ecology, lactic acid bacteria diversity, yeast functionality, and volatile compound profiling to support authenticity, quality, and safety of traditional foods. She has contributed to studies on Feta, Graviera, Trachanas, and other fermented matrices, as well as to broader themes such as grape and wine microbiomes and probiotic potential of indigenous strains. Her scholarly output includes 11 peer-reviewed documents, encompassing original research articles, review papers, and book chapters published in international journals and edited volumes. Collectively, her work has received 340 citations and reflects a sustained impact in the fields of food microbiology, dairy technology, and fermentation science, with an established h-index of 9, highlighting both productivity and citation influence within her research domain.

Citation Metrics (Scopus)

400

300

200

100

0

 

340
Citations

11
Documents

9
h-index

Citations

Documents

h-index

Featured Publications

Marino Venerito | Microbiology | Excellence in Translational Medicine Award

Published on by Medical Lab Scientist

Prof. Dr. Marino Venerito | Microbiology | Excellence in Translational Medicine Award

Senior Physician | Medical school in Magdeburg | Germany

Dr. Marino Venerito is a research-focused scholar whose work centers on gastrointestinal oncology, inflammatory diseases, and translational clinical outcomes. His publications emphasize evidence generation in hepatocellular carcinoma, gastric and colorectal malignancies, Helicobacter pylori–associated disorders, and real-world therapeutic effectiveness. Through multicenter studies, registry-based analyses, and retrospective cohorts, his research contributes to risk stratification, treatment optimization, and prognostic modeling in complex digestive diseases. He has authored 135 peer-reviewed documents spanning original research, collaborative analyses, and consensus-driven investigations, reflecting sustained engagement in high-impact clinical research. His scientific output has accumulated 3,653 citations, demonstrating broad international uptake and relevance across oncology and gastroenterology disciplines. With an h-index of 30, his body of work illustrates consistent citation performance and long-term influence, particularly in studies addressing treatment sequencing, outcome prediction, and population-level clinical data. Overall, his research portfolio highlights methodological rigor, collaborative scope, and measurable impact on contemporary gastrointestinal cancer research and informs future evidence-based clinical practice.

Citation Metrics (Scopus)

4000
3000
2000
1000
0

3653
Citations

135
Documents

30
h-index

Citations

Documents

h-index

Featured Publications

Sourabh Kumar | Microbiology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Sourabh Kumar | Microbiology | Research Excellence Award

Assistant Professor | Maharishi Markandeshwar Medical College and Hospital | India

Dr. Sourabh Kumar is an academic pathologist with a focused research portfolio spanning infectious diseases, hematopathology, and cardiovascular biomarkers. His scholarly work emphasizes Mycoplasma pneumoniae–associated pediatric respiratory infections and the clinicopathological relevance of platelet parameters and von Willebrand factor in valvular heart disease, particularly aortic stenosis. He has authored peer-reviewed articles in national and international medical journals and has contributed extensively to standard microbiology textbooks through multiple invited chapters covering infective syndromes, autoimmunity, hypersensitivity reactions, biomedical waste management, and microscopy. His research output demonstrates a translational approach, integrating laboratory diagnostics with clinical disease severity and prognostication. The body of work reflects sustained academic engagement, with 33 citations, 2 citable research documents, and an h-index of 1, indicating emerging impact in pathology and clinical microbiology literature.

Citation Metrics (Scopus)

40
30
20
10
0

33
Citations

2
Documents

1
h-index

Citations

Documents

h-index

Featured Publications

Debasish Biswal | Microbiology | Young Scientist Award

Published on by Medical Lab Scientist

Assist. Prof. Dr. Debasish Biswal | Microbiology | Young Scientist Award

Assistant Professor | All India Institute of Medical Sciences | India

Dr. Debasish Biswal is a medical microbiologist with a strong research portfolio focused on antimicrobial resistance, molecular diagnostics, infection prevention, and intensive-care–associated infections. His scholarly output comprises 26 peer-reviewed research documents, collectively accruing 45 citations with an h-index of 4, reflecting sustained impact across clinical and translational microbiology. His work spans carbapenemase detection, synergy testing of novel β-lactam/β-lactamase inhibitor combinations, rapid molecular diagnostics for bacterial meningitis and tuberculosis, and genomic epidemiology of multidrug-resistant pathogens. He has contributed to high-impact journals in medical microbiology, critical care, infectious diseases, and parasitology, often integrating laboratory diagnostics with clinical outcomes and infection control strategies. Ongoing research includes evaluation of next-generation antimicrobial combinations against extensively drug-resistant organisms and assessment of advanced molecular platforms for extrapulmonary tuberculosis. His research emphasizes evidence-based antimicrobial stewardship, surveillance of healthcare-associated infections, and translational diagnostics to inform policy and clinical practice.

Citation Metrics (Scopus)

50
40
30
20
10
0

45
Citations

26
Documents

4
h-index

Citations

Documents

h-index

Featured Publications

Foroogh Nejatollahi | Medical Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Foroogh Nejatollahi | Medical Microbiology | Best Researcher Award

Professor at Shiraz University of Medical Sciences, Iran

Dr. Foroogh Nejatollahi is a distinguished Iranian-Canadian immunologist renowned for her contributions to cancer immunotherapy and antibody engineering. With over three decades of academic and research experience, she has significantly advanced the field of immunodiagnostics and human recombinant antibodies. Her career spans key professorial roles and impactful publications that have positioned her as a leader in cancer biology and molecular immunology. She is the inventor of patented antibody-based therapeutics and continues to inspire through her groundbreaking work in antibody design for oncology.

profile

scopus

Education

Dr. Nejatollahi began her academic journey with a BSc in Biology from Shiraz University in 1985. Her passion for life sciences led her to complete an MSc in Microbiology at Shiraz University of Medical Sciences in 1990, where she later returned as a faculty member. Her academic excellence culminated in a PhD in Pathological Sciences from the University of Manchester, UK, in 2002. This robust academic foundation underpins her extensive research into human antibodies and immune responses against cancer and infectious diseases.

Experience

Over a rich academic tenure, Dr. Nejatollahi served as a Professor at Shiraz University of Medical Sciences from 2015 until her early retirement in 2022. Her previous roles included Associate Professor (2011–2015) and Assistant Professor (2007–2011). Earlier in her career, she was a tutor in Microbiology and Immunology at Jahrom University of Medical Sciences. Beyond teaching, she has mentored PhD, MSc, and MD students, delivering courses in immunology, molecular biology, vaccine technology, and antibody engineering, shaping the next generation of scientists and clinicians.

Research Interest

Her multidisciplinary research interests encompass immunobiology, immunodiagnostics, pathobiology, infection and immunity, and human recombinant antibodies. A major focus of her work lies in cancer biology, especially in developing antibody-based diagnostic and therapeutic agents. Dr. Nejatollahi’s research is notable for using phage display technology to isolate single-chain variable fragments (scFvs) and targeting specific cancer biomarkers like HER2, HER3, EGFR, and CD146. These contributions have propelled advances in cancer-targeted immunotherapy and personalized medicine.

Awards

Dr. Nejatollahi holds the US Patent No. US10905771B2 for her invention titled “Anti-MUC18 Human Immunotoxin and Applications Thereof,” a remarkable milestone that exemplifies her innovation in therapeutic antibody development. Her scientific excellence has been acknowledged through numerous conference presentations, both internationally and nationally, including in Canada, the UK, Italy, and Iran. She has represented Iran at global events on cancer therapeutics, HIV/AIDS, and antibody technology, marking her presence as a thought leader in immunological science.

Publications

Among her extensive body of work, the following are key publications with high citation relevance:

Nejatollahi F. et al. (2002). “Neutralizing human recombinant antibodies to human cytomegalovirus gB and gH.” FEMS Immunology and Medical Microbiology, 34:237–244. [Cited by 81 articles]

Nejatollahi F. et al. (2012). “Down-regulation of VEGF expression by anti-HER2/neu single chain antibodies.” Medical Oncology, 26:378–383. [Cited by 54 articles]

Nejatollahi F. et al. (2013). “Deregulation of HER2 downstream signaling in breast cancer cells by a cocktail of anti-HER2 scFvs.” Oncology Research, 20(8):333–340. [Cited by 37 articles]

Nejatollahi F. et al. (2013). “Antiproliferative and apoptotic effects of anti-Prostate Stem Cell scFv antibody on prostate cancer cells.” Journal of Oncology, 2013:839831. [Cited by 29 articles]

Nejatollahi F. et al. (2014). “Triple blockade of HER2 by a cocktail of scFv antibodies in breast cancer.” Tumor Biology, 35(8):7887–7895. [Cited by 45 articles]

Mohammadi M., Nejatollahi F. et al. (2016). “In silico analysis of tag polypeptides in scFv antibodies.” Journal of Theoretical Biology, 402:100–106. [Cited by 23 articles]

Nejatollahi F. et al. (2017). “Anti-FZD7 scFv antibody inhibits cell growth in colorectal cancer.” Applied Biochemistry and Biotechnology, 181:379–390. [Cited by 31 articles]

Conclusion

In conclusion, Professor Foroogh Nejatollahi exemplifies the highest standards of academic excellence, research innovation, and clinical relevance. Her multi-faceted contributions to antibody engineering, cancer immunotherapy, and infectious disease diagnostics not only advance scientific frontiers but also hold transformative potential in medicine. Her scholarly impact, patent portfolio, and mentorship legacy make her a distinguished and deserving nominee for the Best Researcher Award. Her career stands as a beacon of dedication to translational research and global scientific collaboration.

lipeng zhong | Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Mr. lipeng zhong | Microbiology | Best Researcher Award

Associate professor at First Affiliated Hospital of Nanchang University, China

Lipeng Zhong is an accomplished Associate Professor at the First Affiliated Hospital of Nanchang University with a PhD and a focus on microbiology and pharmaceutical sciences. With a career rooted in the fight against bacterial resistance, he has made significant strides in antimicrobial peptide design, the development of antibiotic sensitizers, and exploring the mechanisms behind bacterial resistance. His efforts have been recognized through various research projects and publications, demonstrating a commitment to both theoretical exploration and practical innovation in medical laboratory science.

profile

orcid

Education

Dr. Zhong holds a PhD, which laid the foundation for his deep engagement with biomedical and microbiological research. His advanced academic training enabled him to explore molecular biology, biochemistry, and pharmaceutical interventions in bacterial diseases. His education reflects a rigorous understanding of both clinical and laboratory sciences, equipping him with the theoretical and applied knowledge necessary for innovation in antimicrobial therapies.

Experience

With his current role as Associate Professor at the First Affiliated Hospital of Nanchang University, Dr. Zhong has cultivated extensive experience in academia and research. He has led three provincial and ministerial-level projects and collaborated with interdisciplinary teams, reinforcing his expertise in antimicrobial development. His participation in both teaching and scientific research has allowed him to mentor emerging scientists while pushing forward the frontiers of infectious disease treatment. His consultancy and possible industry partnerships also reflect a translational approach to scientific knowledge, bridging research and application.

Research Interest

Dr. Zhong’s research interests lie at the intersection of antimicrobial innovation and resistance mechanisms. He is deeply invested in the design of antimicrobial peptides—bioactive molecules capable of targeting resistant bacterial strains—and the use of antibiotic sensitizers, which enhance the efficacy of existing drugs. His work also explores bacterial resistance pathways, aiming to develop novel therapeutic strategies that can circumvent or disrupt microbial defense systems. These interests are driven by global healthcare challenges posed by multidrug-resistant infections.

Award

In recognition of his outstanding contributions to medical laboratory science and antimicrobial research, Dr. Zhong has been nominated for awards such as the Outstanding Scientist Award and Best Researcher Award. His academic productivity, innovative spirit, and impact on public health research qualify him for such honors. His work not only advances science but also aligns with the broader goals of improving clinical outcomes through better diagnostics and treatments.

Publication

Dr. Zhong has published five peer-reviewed articles in SCI-indexed journals, focusing on antimicrobial peptides and antibiotic sensitizers. These include:

“Mechanism of Action of a Novel Antimicrobial Peptide on Gram-negative Bacteria,” published in Frontiers in Microbiology (2021) – cited by 36 articles.

“Antibiotic Sensitizers: A New Strategy Against Multidrug Resistance,” in Journal of Antimicrobial Chemotherapy (2020) – cited by 48 articles.

“Design and Synthesis of Peptide-based Antibiotics for Resistant Strains,” published in Peptides (2019) – cited by 27 articles.

“Bacterial Resistance Mechanisms and Therapeutic Interventions,” in Infection and Drug Resistance (2022) – cited by 15 articles.

“Improving Drug Efficacy with Peptide Conjugates,” published in International Journal of Antimicrobial Agents (2023) – cited by 9 articles.
These publications have contributed valuable insights to the ongoing discourse on resistance management and novel therapeutic development, and collectively, they emphasize Dr. Zhong’s sustained scholarly impact.

Conclusion

Considering Dr. Lipeng Zhong’s solid academic background, ongoing research excellence, proven innovation through patents, and impactful contributions to the field of antimicrobial research, he stands as a highly deserving candidate for the Best Researcher Award. His work not only advances scientific understanding but also has the potential to improve public health outcomes globally.